Amy earned a doctorate degree in Microbiology from Louisiana State University in 1997, minoring in virology and molecular biology. After years conducting research on microbial pathogenesis and developing molecular detection methods, Amy began a career with DuPont in food safety diagnostics. In 2012, Amy moved within DuPont Regulatory Affairs and today is the Regulatory Global Lead for the DuPont Probiotics business. Amy’s ability to understand science and regulation, translating to real world industry, enables her to contribute to the forward-thinking probiotics industry platform and lend to the success of DuPont probiotics, all at the current pace of immense industry growth.
There are many aspects of gastrointestinal (GI) health that attribute to overall health. During the stages of life from infancy to elderly, microbiota changes can determine health and happiness, including digestive health, immune response, and even mood. In this presentation, we present an overview of research that demonstrates a positive benefit in establishing a better microbiota through both HMO and probiotic intervention. The presentation highlights the role of GI microbiota in producing beneficial metabolites, resulting in specific health benefits throughout various stages of life.